Furthermore, patients with two ε4 alleles are more likely to develop FAD than those with a single ε4 allele and other subtypes of AD, indicating that increased APOE ε4 gene dosage may promote the development of FAD (Jia et al. 2020c). The gene discussed is APOE; the disease is familial Alzheimer disease.